Combined haemoperfusion, haemofiltration and haemodialysis for systemic detoxification in locoregional 5-fluorouracil therapy.

Cancer Chemother Pharmacol

Free University of Berlin, Medical Center Steglitz, Department of Internal Medicine and Nephrology, Federal Republik of Germany.

Published: February 1992

Combined haemoperfusion, haemofiltration and haemodialysis (HPFD) was examined for its systemic effect on 5-fluorouracil (5-FU) kinetics after locoregional application to one female patient with liver metastases of a colon carcinoma. During each HPFD treatment, which lasted 4 h, 5-FU was given via a port-a-cath system into the hepatic artery on 4 separate days. The HPFD extraction rate was 99%. Extracorporal 5-FU clearance (89 ml/min) was 9% of total body clearance (1094 ml/min). The fraction eliminated within 4 h was only 6% of the applied dose (3500-4000 mg 5-FU). Sufficient extracorporal detoxification during combined HPFD can thus not be guaranteed in locoregional chemotherapy with a high dose of 5-FU.

Download full-text PDF

Source
http://dx.doi.org/10.1007/BF00687329DOI Listing

Publication Analysis

Top Keywords

combined haemoperfusion
8
haemoperfusion haemofiltration
8
haemofiltration haemodialysis
8
5-fu
5
haemodialysis systemic
4
systemic detoxification
4
detoxification locoregional
4
locoregional 5-fluorouracil
4
5-fluorouracil therapy
4
therapy combined
4

Similar Publications

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!